Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 282

Similar articles for PubMed (Select 23111181)

1.

Argon laser with and without anti-vascular endothelial growth factor therapy for extrafoveal polypoidal choroidal vasculopathy.

Gemmy Cheung CM, Yeo I, Li X, Mathur R, Lee SY, Chan CM, Wong D, Wong TY.

Am J Ophthalmol. 2013 Feb;155(2):295-304.e1. doi: 10.1016/j.ajo.2012.08.002. Epub 2012 Oct 27.

PMID:
23111181
2.

1-year results of combined half-dose photodynamic therapy and ranibizumab for polypoidal choroidal vasculopathy.

Wong IY, Shi X, Gangwani R, Zhao P, Iu LP, Li Q, Ng A, Li X.

BMC Ophthalmol. 2015 Jun 30;15(1):66. doi: 10.1186/s12886-015-0061-8.

3.

One-Year Results of Intravitreal Aflibercept for Polypoidal Choroidal Vasculopathy.

Yamamoto A, Okada AA, Kano M, Koizumi H, Saito M, Maruko I, Sekiryu T, Iida T.

Ophthalmology. 2015 Jun 15. pii: S0161-6420(15)00507-2. doi: 10.1016/j.ophtha.2015.05.024. [Epub ahead of print]

PMID:
26088619
4.

Structural changes of the choroid in sarcoid- and tuberculosis-related granulomatous uveitis.

Mehta H, Sim DA, Keane PA, Zarranz-Ventura J, Gallagher K, Egan CA, Westcott M, Lee RW, Tufail A, Pavesio CE.

Eye (Lond). 2015 May 29. doi: 10.1038/eye.2015.65. [Epub ahead of print]

PMID:
26021867
5.

Identification of Underlying Causes of Spontaneous Submacular Hemorrhage by Indocyanine Green Angiography.

Kim H, Lee SC, Kim SM, Lee JH, Koh HJ, Kim SS, Byeon SH, Kim M, Lee CS.

Ophthalmologica. 2015;233(3-4):146-54. doi: 10.1159/000380830. Epub 2015 Mar 26.

PMID:
25833061
6.

Treatment outcomes in eyes with polypoidal choroidal vasculopathy with poor baseline visual acuity.

Kim JH, Kim JW, Lee TG, Lew YJ.

J Ocul Pharmacol Ther. 2015 May;31(4):241-7. doi: 10.1089/jop.2014.0145. Epub 2015 Mar 18.

PMID:
25786032
7.

Aflibercept therapy for polypoidal choroidal vasculopathy: short-term results of a multicentre study.

Koizumi H, Kano M, Yamamoto A, Saito M, Maruko I, Sekiryu T, Okada AA, Iida T.

Br J Ophthalmol. 2015 Mar 16. pii: bjophthalmol-2014-306432. doi: 10.1136/bjophthalmol-2014-306432. [Epub ahead of print]

PMID:
25777816
8.

EVEREST study report 2: imaging and grading protocol, and baseline characteristics of a randomised controlled trial of polypoidal choroidal vasculopathy.

Tan CS, Ngo WK, Chen JP, Tan NW, Lim TH; EVEREST Study Group.

Br J Ophthalmol. 2015 May;99(5):624-8. doi: 10.1136/bjophthalmol-2014-305674. Epub 2015 Mar 10.

9.

THREE-YEAR RESULTS OF POLYPOIDAL CHOROIDAL VASCULOPATHY TREATED WITH PHOTODYNAMIC THERAPY: Retrospective Study and Systematic Review.

Wong CW, Cheung CM, Mathur R, Li X, Chan CM, Yeo I, Wong E, Lee SY, Wong D, Wong TY.

Retina. 2015 Feb 24. [Epub ahead of print]

PMID:
25719986
10.

Six-month results of intravitreal aflibercept injections for patients with polypoidal choroidal vasculopathy.

Hosokawa M, Shiraga F, Yamashita A, Shiragami C, Ono A, Shirakata Y, Kimura S, Shiode Y, Kawata T, Hosogi M, Fujiwara A, Morizane Y.

Br J Ophthalmol. 2015 Feb 23. pii: bjophthalmol-2014-305275. doi: 10.1136/bjophthalmol-2014-305275. [Epub ahead of print]

PMID:
25712826
12.

One-year result of aflibercept treatment on age-related macular degeneration and predictive factors for visual outcome.

Oishi A, Tsujikawa A, Yamashiro K, Ooto S, Tamura H, Nakanishi H, Ueda-Arakawa N, Miyake M, Akagi-Kurashige Y, Hata M, Yoshikawa M, Kuroda Y, Takahashi A, Yoshimura N.

Am J Ophthalmol. 2015 May;159(5):853-60.e1. doi: 10.1016/j.ajo.2015.01.018. Epub 2015 Jan 26.

PMID:
25634529
13.

The natural history of polypoidal choroidal vasculopathy: a multi-center series of untreated Asian patients.

Cheung CM, Yang E, Lee WK, Lee GK, Mathur R, Cheng J, Wong D, Wong TY, Lai TY.

Graefes Arch Clin Exp Ophthalmol. 2015 Jan 27. [Epub ahead of print]

PMID:
25619667
14.

Choroidal thickness and choroidal blood flow after intravitreal bevacizumab injection in eyes with central serous chorioretinopathy.

Okamoto M, Matsuura T, Ogata N.

Ophthalmic Surg Lasers Imaging Retina. 2015 Jan;46(1):25-32. doi: 10.3928/23258160-20150101-04.

PMID:
25559505
15.

Short-term changes in choroidal thickness after aflibercept therapy for neovascular age-related macular degeneration.

Koizumi H, Kano M, Yamamoto A, Saito M, Maruko I, Kawasaki R, Sekiryu T, Okada AA, Iida T.

Am J Ophthalmol. 2015 Apr;159(4):627-33. doi: 10.1016/j.ajo.2014.12.025. Epub 2014 Dec 30.

PMID:
25555799
16.

Submacular hemorrhage in polypoidal choroidal vasculopathy treated by vitrectomy and subretinal tissue plasminogen activator.

Kimura S, Morizane Y, Hosokawa M, Shiode Y, Kawata T, Doi S, Matoba R, Hosogi M, Fujiwara A, Inoue Y, Shiraga F.

Am J Ophthalmol. 2015 Apr;159(4):683-9. doi: 10.1016/j.ajo.2014.12.020. Epub 2014 Dec 30.

PMID:
25555798
17.

En face imaging of the choroid in polypoidal choroidal vasculopathy using swept-source optical coherence tomography.

Alasil T, Ferrara D, Adhi M, Brewer E, Kraus MF, Baumal CR, Hornegger J, Fujimoto JG, Witkin AJ, Reichel E, Duker JS, Waheed NK.

Am J Ophthalmol. 2015 Apr;159(4):634-43. doi: 10.1016/j.ajo.2014.12.012. Epub 2014 Dec 19.

PMID:
25528955
18.

Prognostic factors of 2-year outcomes of ranibizumab therapy for polypoidal choroidal vasculopathy.

Hikichi T, Kitamei H, Shioya S.

Br J Ophthalmol. 2015 Jun;99(6):817-22. doi: 10.1136/bjophthalmol-2014-305606. Epub 2014 Dec 5.

PMID:
25480464
19.

Reduced-fluence photodynamic therapy in polypoidal choroidal vasculopathy nonresponsive to ranibizumab.

Byon IS, Kwon HJ, Kim SI, Shin MK, Park SW, Lee JE.

Ophthalmic Surg Lasers Imaging Retina. 2014 Nov-Dec;45(6):534-41. doi: 10.3928/23258160-20141118-08.

PMID:
25423633
20.

Stereotactic radiotherapy for polypoidal choroidal vasculopathy: a pilot study.

Introini U, Casalino G, Triolo G, O'Shaughnessy D, Shusterman EM, Chakravarthy U, Slakter JS, Bandello F.

Ophthalmologica. 2015;233(2):82-8. doi: 10.1159/000368561. Epub 2014 Nov 15.

PMID:
25402871
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk